Maxim Group Initiates Coverage On Brooklyn with Buy Rating, Announces Price Target of $20
Maxim Group analyst Jason McCarthy initiates coverage on Brooklyn (AMEX:BTX) with a Buy rating and announces Price Target of $20.
48 Biggest Movers From Yesterday
Gainers
Edesa Biotech, Inc. (NASDAQ: EDSA) shares climbed 102.7% to settle at $11.92 on Monday after the company disclosed Phase 2 data of its monoclonal antibody in hospitalized COVID-19 patients.
Analyzing Brooklyn’s Unusual Options Activity
Brooklyn (AMEX:BTX) shares experienced unusual options activity on Friday. The stock price moved down to $11.14 following the option alert.
Understanding Brooklyn’s Unusual Options Activity
On Monday, shares of Brooklyn (AMEX:BTX) saw unusual options activity. After the option alert, the stock price moved up to $11.11.
54 Biggest Movers From Yesterday
Gainers
Sight Sciences, Inc. (NASDAQ: SGHT) shares jumped 39.6% to settle at $33.50 on Thursday as the company priced its IPO at $24 per share.
32 Stocks Moving In Thursday’s Mid-Day Session
Gainers
ATA Creativity Global (NASDAQ: AACG) shares jumped 37.8% to $4.1050.
Neurodegenerative Disease, Cancer Stocks Among Top Biotech Gainers In 2021
Biotech stocks underperformed the broader market in the first half of 2021, with the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) advancing about 8% year-to-date compared to the roughly 14% gain for the S&P 500 Index.